María Josefa
Pajares Villandiego
Publicaciones en las que colabora con María Josefa Pajares Villandiego (11)
2021
-
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337
2018
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2016
-
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer
Molecular Oncology, Vol. 10, Núm. 9, pp. 1437-1449
-
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694
2014
-
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
British Journal of Cancer, Vol. 110, Núm. 6, pp. 1545-1551
2013
-
Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer
Journal of the National Cancer Institute, Vol. 105, Núm. 18, pp. 1385-1393
-
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC
International Journal of Cancer, Vol. 132, Núm. 9, pp. 1986-1995
2012
-
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression
Journal of Immunology, Vol. 189, Núm. 9, pp. 4674-4683
2010
-
TGFBI expression is associated with a better response to chemotherapy in NSCLC
Molecular Cancer, Vol. 9